thrombocytopenia

  1. Covaxin shows excellent safety track record: Bharat Biotech quits study citing risks

    Covaxin shows excellent safety track record: Bharat Biotech quits study citing risks

    The study led by Banaras Hindu University (BHU) claimed that Covaxin increases the risk of stroke and rare Guillain-Barré syndrome."Multiple studies have been conducted on the safety of Covaxin, and I have published it in peer-reviewed journals, demonstrating an excellent safety track record,"...
  2. AstraZeneca withdraws COVID-19 vaccine, citing excess of updated vaccines available

    AstraZeneca withdraws COVID-19 vaccine, citing excess of updated vaccines available

    New Delhi, UK-based pharmaceutical major AstraZeneca has started withdrawing its Covid-19 vaccine, which was provided in India as 'Covishield' in partnership with the Serum Institute of India, days after it released a blood test... Had acknowledged the rare side effects of clotting and reducing...
  3. Plea in Supreme Court seeks medical panel under retired apex court judge to probe side effects of Covishield

    Plea in Supreme Court seeks medical panel under retired apex court judge to probe side effects of Covishield

    In the application filed by lawyer Vishal Tiwari, it has been said that after Covid-19, cases of death due to heart attack among youth have increased and people have died suddenly and a demand has been made to give instructions to the Central Government. This has been done to establish vaccine...
  4. Some vaccines cause clots in blood vessels in rare cases: medical expert amid reports on AstraZeneca

    Some vaccines cause clots in blood vessels in rare cases: medical expert amid reports on AstraZeneca

    New Delhi [India], medical expert Dr Rajeev Jayadevan said thrombocytopenia syndrome (TTS) refers to clots in the blood vessels, and it occurs in very rare cases after the use of certain types of vaccines, admitting that While Covid vaccines have helped prevent many deaths, Jayadevan, who is...
Back
Top